XTANT MEDICAL HOLDINGS, INC. Quantifying Misstatement in Current Year Financial Statements, Amount
XTANT MEDICAL HOLDINGS, INC. (XTNT) reported Quantifying Misstatement in Current Year Financial Statements, Amount of $155.20 million for the 3-month period ending 2018-06-30, per its 10-Q filed 2019-08-08.
Discontinued › Notes
us-gaap:QuantifyingMisstatementInCurrentYearFinancialStatementsAmount · last filed 2019-08-08
- XTANT MEDICAL HOLDINGS, INC. quantifying misstatement in current year financial statements, amount for the quarter ending 2018-06-30 was $155.20M.
| Period end | Quantifying Misstatement in Current Year Financial Statements, Amount 3 month | Quantifying Misstatement in Current Year Financial Statements, Amount 6 month |
|---|---|---|
| 2018-06-30 | $155.20M 10-Q · filed 2019-08-08 | $155.20M 10-Q · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |